MISC

2001年5月

Alleviation of myocardial ischemia after Kawasaki disease by heparin and exercise therapy

CIRCULATION
  • S Tateno
  • ,
  • M Terai
  • ,
  • K Niwa
  • ,
  • T Jibiki
  • ,
  • H Hamada
  • ,
  • K Yasukawa
  • ,
  • T Honda
  • ,
  • S Oana
  • ,
  • Y Kohno

103
21
開始ページ
2591
終了ページ
2597
記述言語
英語
掲載種別
出版者・発行元
LIPPINCOTT WILLIAMS & WILKINS

Background-Heparin promotes angiogenesis. We evaluated the effects of combined treatment with heparin and exercise on myocardial ischemia in the chronic stage of Kawasaki disease.
Methods and Results-This study was conducted in 7 patients (aged 6 to 19 years) who had a totally occluded coronary artery and stress-induced myocardial ischemia in the collateral-dependent areas. Twice-daily exercise using a bicycle ergometer was performed with increments of 0.5 W/kg every 3 minutes up to maximal exertion for 10 days. Heparin, which immediately increased circulating hepatocyte growth factor, was given intravenously 10 minutes before each exercise period. Newly developed myocardial infarction, ventricular tachyarrhythmia, anginal attack, or hemorrhagic complication was not observed in any patient. Dipyridamole-loading single photon emission computed tomography documented improved myocardial perfusion in the collateral-dependent areas and a significant reduction in total defect scores in all patients after the completion of 20 sessions (P=0.01). In control patients who did not receive the heparin-exercise therapy, however, stress defect scores remained unchanged (n=1) or increased (n=2) during follow-up. Computerized quantitative coronary angiography provided evidence that the heparin-exercise therapy increased the diameter of the occluded artery to which collaterals terminated (P=0.001) but not that of the reference artery with which collaterals were not connected (P=0.96).
Conclusions-The findings suggest that a series of heparin and exercise treatments over 10 days may have a dramatic effect on the alleviation of myocardial ischemia in colateral-dependent regions. This may be a safe, noninvasive revascularization therapy for patients with coronary artery occlusion in the chronic stage of Kawasaki disease.

リンク情報
Web of Science
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000169012800023&DestApp=WOS_CPL
ID情報
  • ISSN : 0009-7322
  • Web of Science ID : WOS:000169012800023

エクスポート
BibTeX RIS